tirzepatide court case update Is Legal in 2026? FDA Status, Compounding Ban & FDA Zepbound shortage ends, impacts

Aditi Kantipuly and (the other) Peter Singer made the case in STAT in March 2026: BMI thresholds derived from American populations miss obesity in Asian patients, who face greater cardio-metabolic risk at lower BMI

The answer is no, as Ozempic works differently and has a different action profile

No aplicar en piel irritada o lesionada

Another key point: stopping therapy leads to regain in most people, which argues for getting to and staying at an effective maintenance dose rather than hovering at subtherapeutic levels

Sterile Technique: Maintaining strict sterile technique throughout the administration process is non-negotiable